Tenon Medical(R) Receives Approval for Notice of Allowance from the European Patent Office
Tenon Medical (NASDAQ:TNON) has received approval for two additional patents from the European Patent Office for their Catamaran SI Joint Fixation Device. The patents, which will be granted within the European Community, are focused on the company's novel sacroiliac joint prostheses technology. According to Richard Ginn, Co-Founder and Chief Technology Officer, this approval strengthens Tenon's global patent portfolio and demonstrates their dedication to innovation in treating Sacroiliac Joint (SIJ) disorders.
Tenon Medical (NASDAQ:TNON) ha ricevuto l'approvazione per due ulteriori brevetti dall'Ufficio Europeo dei Brevetti per il loro Dispositivo di Fissazione SI Catamaran. I brevetti, che saranno concessi all'interno della Comunità Europea, si concentrano sulla tecnologia innovativa delle protesi dell'articolazione sacroiliaca dell'azienda. Secondo Richard Ginn, Co-Fondatore e Direttore Tecnico, questa approvazione rafforza il portafoglio di brevetti globale di Tenon e dimostra il loro impegno per l'innovazione nel trattamento dei disturbi dell'articolazione sacroiliaca (SIJ).
Tenon Medical (NASDAQ:TNON) ha recibido la aprobación para dos patentes adicionales de la Oficina Europea de Patentes para su Dispositivo de Fijación SI Catamaran. Las patentes, que se concederán dentro de la Comunidad Europea, se centran en la tecnología innovadora de prótesis de la articulación sacroilíaca de la empresa. Según Richard Ginn, Co-Fundador y Director de Tecnología, esta aprobación refuerza el portafolio global de patentes de Tenon y demuestra su dedicación a la innovación en el tratamiento de los trastornos de la articulación sacroilíaca (SIJ).
Tenon Medical (NASDAQ:TNON)는 Catamaran SI 관절 고정 장치에 대해 유럽 특허청으로부터 두 개의 추가 특허 승인을 받았습니다. 이 특허는 유럽 공동체 내에서 부여될 예정이며, 회사의 혁신적인 천장관절 보철 기술에 중점을 두고 있습니다. 공동 창립자이자 최고 기술 책임자인 리차드 긴(Richard Ginn)에 따르면, 이번 승인은 Tenon의 글로벌 특허 포트폴리오를 강화하고 천장관절(SIJ) 장애 치료에 대한 혁신에 대한 헌신을 보여줍니다.
Tenon Medical (NASDAQ:TNON) a reçu l'approbation pour deux brevets supplémentaires de l'Office Européen des Brevets pour leur Dispositif de Fixation SI Catamaran. Les brevets, qui seront accordés au sein de la Communauté Européenne, se concentrent sur la technologie novatrice des prothèses de l'articulation sacro-iliaque de l'entreprise. Selon Richard Ginn, Co-Fondateur et Directeur Technique, cette approbation renforce le portefeuille mondial de brevets de Tenon et démontre leur engagement envers l'innovation dans le traitement des troubles de l'articulation sacro-iliaque (SIJ).
Tenon Medical (NASDAQ:TNON) hat die Genehmigung für zwei weitere Patente vom Europäischen Patentamt für ihr Catamaran SI Gelenkfixierungsgerät erhalten. Die Patente, die innerhalb der Europäischen Gemeinschaft gewährt werden, konzentrieren sich auf die neuartige Technologie der Sacroiliac-Gelenkprothesen des Unternehmens. Laut Richard Ginn, Mitbegründer und Chief Technology Officer, stärkt diese Genehmigung Tenons globales Patentportfolio und zeigt ihr Engagement für Innovationen bei der Behandlung von Sacroiliac-Gelenk (SIJ)-Erkrankungen.
- Secured two new European patents strengthening intellectual property protection
- Expanded international patent portfolio for Catamaran SI Joint Fixation Device
- None.
LOS GATOS, CA / ACCESS Newswire / March 10, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) disorders, announced today the Company has been notified by the European patent office that two additional patents directed to the novel Catamaran SI Joint Fixation Device have been approved for grant of a European patent within the European Community.
"The Tenon Medical team is pleased to receive recognition from the European Community for our novel Catamaran® SI joint prostheses," commented Richard Ginn, Co-Founder and Chief Technology Officer of Tenon Medical. "Receiving notification of approval for two additional patents by the European patent office reinforces Tenon's increasingly robust patent position worldwide as well as our commitment to continued innovation."
About Tenon Medical, Inc.
Tenon Medical, Inc., a medical device company formed in 2012, has developed The Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran™ Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. Since the national launch of the Catamaran SI Joint Fusion System in October 2022 Tenon is focused on two commercial opportunities with its System in the SI Joint market which includes: 1) Primary SI Joint procedures, and 2) Revision procedures of failed SI Joint implants. For more information, please visit www.tenonmed.com.
The Tenon Medical logo shown above, and Catamaran®, PiSIF®, CAT PiSIF®, ETAD®, Posterior Inferior Sacroiliac Fusion®, CAT SIJ Fusion System®, Catamaran SIJ Fusion System®, Catamaran Inferior Posterior Fusion System®, Catamaran Transfixation Fusion System®, and Catamaran Transfixation Fusion Device® are registered trademarks of Tenon Medical, Inc. MAINSAILTM is also a trademark of Tenon Medical, Inc.
IR Contact:
Shannon Devine / Rory Rumore
203-741-8811
MZ North America
tenon@mzgroup.us
SOURCE: Tenon Medical, Inc.
View the original press release on ACCESS Newswire
FAQ
What patents did Tenon Medical (TNON) receive approval for in Europe?
How will the new European patents impact Tenon Medical's (TNON) market position?
What medical condition does Tenon Medical's (TNON) Catamaran device treat?
When did Tenon Medical (TNON) receive the European patent approval notice?
